We are a multidisciplinary team with a solid experience in Neurology, medical expertise and healthcare ventures
Alicia Martínez Piñeiro (CEO, CMO)
Neurologist focused on Neuromuscular disorders as well as functional test of central and peripheral nerve system, including Intraoperative Monitoring (IOM) of evoked potentials. Dr. Martínez-Piñeiro obtained the “Río Hortega” grant by the Instituto de Salud Carlos III (Spanish Health Ministry). She followed different IOM observership at Hyman-Newman Institute of Neurology and Neurosurgery of St.Luke’s Roosevelt Hospital in New York, Intraoperative Neurophysiology Unit of Bellvitge University Hospital and Istituto Clinico Humanitas (Milano). From 2014, she has implemented a clinical and training IOM program at University Hospital Germans Trias i Pujol (HUGTiP, Barcelona). Chief of the Neuromuscular and Electrodiagnostic Unit and Chief Intraoperative Monitoring Unit of HUGTiP. Her clinical research has focused on the application of electrodiagnostic techniques in neurovascular pathology. She has obtained competitive grants from “La Marató TV3 Foundation”, “La Caixa Foundation” with the research project: “New predictive biomarkers of functional recovery prior the endovascular treatment of acute ischemic stroke. PROMISE (somatosensory evoked POtEntials MonItoring during acute ischemic StrokE) Study” (ClinicalTrials.gov: NCT04099615). She is also the inventor of the patent “Prediction of the outcome of endovascular treatment in acute ischemic stroke patients” (NºPCT/EP2018/053899, no.:EP17382078.8). From an academic perspective, she has participated as speaker at national and international conferences and she cooperates with post-doctoral programs related to IOM and electrodiagnostic of Universitat de Barcelona and Universitat de Girona.
Dr. Antoni Dávalos Errando (CSO)
Internationally renowned Key Opinion Leader in stroke. Dr. Dávalos leads the Neurovascular Unit at the HUGTiP, considered an outstanding group in neurovascular research and acute stroke treatment, both in national and international scientific activities. He maintains scientific collaborations with the Stroke Center at the UPMC (Pittsburgh, PA) and the HERMES Trialists Network on the primary topic of this project: Mechanical Thrombectomy in Acute Ischemic Stroke. His clinical research has focused on the acute phase of stroke, particularly on the mechanisms associated with neurological deterioration, hemorrhagic transformation and brain edema, and in reperfusion therapies. Dr. Davalos has been principal investigator or on the steering committee in a number of drug trials on acute stroke such as the SITS-MOST, DIAS & DIAS-2, DIAS-3, ECASS II and ECASS III on thrombolytic therapy, STAR on mechanical thrombectomy, and SAINT I & II and ICTUS on neuroprotection. He is co-PI of REVASCAT trial, creating a turning point in stroke therapy and establishing a level A of evidence of the clinical benefit of mechanical thrombectomy in acute ischemic stroke with health, social and economic consequences.
Raül Zurita PhD, MBA (COO)
Over 15 years in life science industry, with increasingly responsible managing positions in R&D/Project Management, Global Marketing, Business Development and Strategic Innovation.
Successfully managed cross-functional teams for the development of innovative medical devices, from concept development to commercialization/clinical use. Expertise in technology evaluation, business strategy/development and contract negotiation with third parties.
Beside his experience working in a large multinational company, he is passionate about startups. He fostered an extensive network of contacts in academic licensing offices, VCs, biotech and medtech start-ups.
Gisela Ruíz Vega (CTO)
Biomedical engineer specialized in the design of electrochemical biosensors for Point of Care devices.
Postdoctoral researcher at the Catalan Institute of Nanoscience and Nanotechnology (ICN2). She obtained her Bachelor and Master degree in Biomedical engineering from the Polytechnic University of Catalonia. Until 2016, she worked at the SISEMED company as clinical engineer consultant in the elaboration of medical equipment plan projects and technical protocols for prevention and maintenance of electromedical equipment. She received her Electrical and Telecommunication Engineering PhD (2019) at the Autonomous University of Barcelona (UAB) with honors, working in the development of fast and simple electrochemical magneto-biosensors and their integration in Point-of-Care (POC) diagnostic devices.
Role: Technical lead of the device development.
Olivier Resnik (Business Development Director-Israel)
More than 35 years of executive experience in different markets focused on the outcome and concerned for the individuals.
Actually Board member of Adshir Ltd.(hitech startup) and Business consultant for others companies.
Role: Project management & Investment strategy plan”.
Marc Cusachs Farraro (Business Development Advisor)
Bachelor in Biotechnology and Master in Business Management Applied to the Biomedical Sector from the University of Barcelona. Deputy Director of Transplant Biomedicals, spin-off of the Hospital Clínic de Barcelona, where they raised € 6.9M and developed a novel device for the preservation and transport of organs from conception to clinical phases (2016-2018). Head of Innovation and Business Development at the Germans Trias i Pujol Biomedical Research Institute (IGTP), being responsible for 52 innovation projects and leading the achievement of 19 new patents, 9 license agreements and the constitution of 3 spin-off companies (Ahead Therapeutics, Biointaxis and Time is Brain) (2018 to 2020). From early 2020, Marc is Co-founder and COO of Kintsugi Therapeutics, a biotech company focused on the development of a novel treatment for NASH.
Role: Marketing and sales plan advisement. Target key accounts and customers.
Jaume Coll i Cantí (SAB member)
Neurologist with more than 30 years of experience in neuromuscular disorders and electrodiagnostic. He is an expert in electromyography diagnostic techniques.